Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Not yet recruiting · NCT07358195 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, kidney disorder, kidney failure, neoplasm, urinary system disorder | Not yet recruiting | Early phase 1 | 2026-01-22 | NCT07358195 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |